Archegos founder Bill Hwang, CFO charged in stock market fraud
Archegos founder Bill Hwang is free on bail after being formally charged over accusations of a massive stock market fraud.
Read More »
Merck Q1 earnings beat Wall Street’s estimates, raises full-year guidance
CNBC’s Meg Tirrell joins ‘Squawk Box’ to break down the latest first-quarter earnings report from drugmaker Merck, which beat Wall Street’s estimates on the top and bottom lines.
Read More »
We still like some Big Tech stocks, depends on investment horizon, says Nancy Tengler
Nancy Tengler, CEO and CIO at Laffer Tengler Investments, and Gunjan Banerji, markets reporter at the Wall Street Journal, join CNBC’s ‘Squawk Box’ to discuss tech stocks amid a busy week of earnings.
Read More »
Eli Lilly drug tirzepatide meets weight-loss goals in obesity trial
A highly anticipated clinical trial from Eli Lilly showed its Type 2 diabetes drug met its primary endpoints. CNBC’s Meg Tirrell joins ‘Squawk Box’ to break down the results.
Read More »
Wedbush’s Joel Kulina: Microsoft, Apple remain last safe havens of the market
Joel Kulina, Head of Technology/Media Trading at Wedbush Securities, joins Worldwide Exchange to discuss the tech sector outlook ahead of the anticipated Big Tech earnings reports later today.
Read More »
Matt Orton: Information technology, healthcare are areas of interest
Matt Orton of Carillon Tower Advisers joins Worldwide Exchange to give his take on what’s driving the market.
Read More »
Food prices are never going back to where they were in ’19, says Tilman Fertitta
Tilman Fertitta, Fertitta Entertainment chairman, joins ‘Power Lunch’ to discuss how his companies are doing, how inflation is impacting his business and more.
Read More »
There is still significant upside in revenue for payment stocks, says MoffettNathanson’s Ellis
Lisa Ellis, MoffettNathanson partner and senior equity analyst, joins ‘Power Lunch’ to discuss Ellis’ take on payment companies, what’s going with PayPal’s stumbles and execution issues.
Read More »